A. Tadić

1.2k total citations
17 papers, 624 citations indexed

About

A. Tadić is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, A. Tadić has authored 17 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 5 papers in Cognitive Neuroscience. Recurrent topics in A. Tadić's work include Treatment of Major Depression (10 papers), Bipolar Disorder and Treatment (6 papers) and Tryptophan and brain disorders (3 papers). A. Tadić is often cited by papers focused on Treatment of Major Depression (10 papers), Bipolar Disorder and Treatment (6 papers) and Tryptophan and brain disorders (3 papers). A. Tadić collaborates with scholars based in Germany, Switzerland and United States. A. Tadić's co-authors include Klaus Lieb, Stefanie Wagner, Norbert Dahmen, Isabella Helmreich, Bettina K. Doering, Armin Szegedi, Dan Rujescu, Ömür Başkaya, Markus Müller and Hans H. Stassen and has published in prestigious journals such as Acta Psychiatrica Scandinavica, Translational Psychiatry and Archives of Clinical Neuropsychology.

In The Last Decade

A. Tadić

17 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Tadić Germany 10 185 168 158 145 145 17 624
Dorottya Pap Hungary 16 165 0.9× 148 0.9× 125 0.8× 91 0.6× 106 0.7× 34 623
S. De Risio Italy 16 137 0.7× 158 0.9× 120 0.8× 157 1.1× 173 1.2× 26 625
Ciarán Corcoran Ireland 8 326 1.8× 144 0.9× 173 1.1× 95 0.7× 87 0.6× 17 790
Sang‐Woo Hahn South Korea 15 172 0.9× 148 0.9× 112 0.7× 93 0.6× 85 0.6× 45 589
Nick J. Coupland Canada 10 186 1.0× 173 1.0× 116 0.7× 154 1.1× 95 0.7× 12 580
Laura R. Magni Italy 14 277 1.5× 302 1.8× 133 0.8× 148 1.0× 156 1.1× 30 837
Ralph J. Koek United States 14 276 1.5× 284 1.7× 121 0.8× 122 0.8× 92 0.6× 29 675
Giovanni Camardese Italy 22 288 1.6× 281 1.7× 218 1.4× 195 1.3× 162 1.1× 63 995
Riccardo Guglielmo Italy 13 166 0.9× 138 0.8× 108 0.7× 144 1.0× 126 0.9× 29 601
Kirsten Rohde United States 7 140 0.8× 215 1.3× 153 1.0× 104 0.7× 140 1.0× 9 611

Countries citing papers authored by A. Tadić

Since Specialization
Citations

This map shows the geographic impact of A. Tadić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tadić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tadić more than expected).

Fields of papers citing papers by A. Tadić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Tadić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tadić. The network helps show where A. Tadić may publish in the future.

Co-authorship network of co-authors of A. Tadić

This figure shows the co-authorship network connecting the top 25 collaborators of A. Tadić. A scholar is included among the top collaborators of A. Tadić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Tadić. A. Tadić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Engelmann, Jan, Lea Zillich, Josef Frank, et al.. (2022). Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial. Translational Psychiatry. 12(1). 268–268. 11 indexed citations
2.
Frieling, Helge, Klaus Lieb, Stefan Bleich, Alexandra Kotsiari, & A. Tadić. (2014). P.1.a.026 Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. European Neuropsychopharmacology. 24. S169–S169. 1 indexed citations
3.
Tadić, A., et al.. (2013). Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression. Pharmacopsychiatry. 46(7). 261–266. 9 indexed citations
4.
Wagner, Stefanie, Isabella Helmreich, Klaus Lieb, & A. Tadić. (2012). P-539 - A meta-analysis of executive dysfunctions in unipolar major depressive disorder (MDD) without psychotic symptoms and their changes during antidepressant treatment. European Psychiatry. 27. 1–1. 2 indexed citations
5.
Wagner, Stefanie, Bettina K. Doering, Isabella Helmreich, Klaus Lieb, & A. Tadić. (2011). A meta‐analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatrica Scandinavica. 125(4). 281–292. 149 indexed citations
6.
Wagner, Stefanie, Isabella Helmreich, Norbert Dahmen, Klaus Lieb, & A. Tadić. (2011). Reliability of Three Alternate Forms of the Trail Making Tests A and B. Archives of Clinical Neuropsychology. 26(4). 314–321. 119 indexed citations
8.
Dreimüller, Nadine, A. Tadić, Aleksandra Dragičević, et al.. (2011). The Serotonin Transporter Promoter Polymorphism (5-HTTLPR) Affects the Relation between Antidepressant Serum Concentrations and Effectiveness in Major Depression. Pharmacopsychiatry. 45(3). 108–113. 15 indexed citations
9.
Helmreich, Isabella, Stefan Wagner, Roland Mergl, et al.. (2011). The inventory of depressive symptomatology is more sensitive to changes in depressive symptomatology than the hamilton depression rating scale in patients with minor depression. European Psychiatry. 26(S2). 634–634. 1 indexed citations
10.
Wagner, Stefanie, Ömür Başkaya, Norbert Dahmen, Klaus Lieb, & A. Tadić. (2009). Modulatory role of the brain‐derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borderline personality disorder. Genes Brain & Behavior. 9(1). 97–102. 49 indexed citations
13.
Wagner, Stefanie, Ömür Başkaya, Klaus Lieb, Norbert Dahmen, & A. Tadić. (2009). The Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism modulates the effects of serious life events on impulsive aggression in patients with Borderline Personality Disorder. Pharmacopsychiatry. 42(5). 1 indexed citations
14.
Tadić, A. & Klaus Lieb. (2007). Pharmakotherapie bei therapieresistenter Depression. Der Nervenarzt. 78(S3). 551–564. 1 indexed citations
15.
Szegedi, Armin, Dan Rujescu, A. Tadić, et al.. (2004). The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. The Pharmacogenomics Journal. 5(1). 49–53. 116 indexed citations
16.
Tadić, A., Norbert Dahmen, Armin Szegedi, et al.. (2004). Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal?induced seizures and delirium tremens. European Archives of Psychiatry and Clinical Neuroscience. 255(2). 129–135. 17 indexed citations
17.
Tadić, A., Dan Rujescu, Armin Szegedi, et al.. (2002). Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 117B(1). 1–6. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026